Lmcg Investments LLC Increases Holdings in Danaher Corporation $DHR

Key Points

• Lmcg Investments LLC increased its holdings in Danaher Corporation by 11.4%, owning 115,839 shares valued at approximately $22.88 million.
• Danaher recently declared a $0.32 per share quarterly dividend, with a yield of 0.6%, to be paid out on October 31st.
• Financial analysts have given Danaher a consensus rating of "Moderate Buy" and set a target price averaging $244.60 per share.

Lmcg Investments LLC raised its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 11.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 115,839 shares of the conglomerate's stock after buying an additional 11,851 shares during the quarter. Danaher comprises about 1.4% of Lmcg Investments LLC's investment portfolio, making the stock its 13th biggest holding. Lmcg Investments LLC's holdings in Danaher were worth $22,883,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in DHR. Nuveen LLC purchased a new position in Danaher during the first quarter valued at $833,941,000. Invesco Ltd. raised its stake in Danaher by 44.5% during the first quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock valued at $965,259,000 after buying an additional 1,450,703 shares during the last quarter. Baird Financial Group Inc. raised its stake in Danaher by 290.6% during the first quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate's stock valued at $295,550,000 after buying an additional 1,072,617 shares during the last quarter. Generation Investment Management LLP raised its stake in Danaher by 33.2% during the first quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate's stock valued at $651,515,000 after buying an additional 791,662 shares during the last quarter. Finally, Parnassus Investments LLC raised its stake in Danaher by 23.3% during the first quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate's stock valued at $784,745,000 after buying an additional 722,636 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the business's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 11.10% of the company's stock.

Danaher Stock Down 1.0%

Danaher stock opened at $202.53 on Friday. The stock has a market cap of $145.02 billion, a PE ratio of 43.09, a price-to-earnings-growth ratio of 2.91 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a one year low of $171.00 and a one year high of $279.41. The stock has a fifty day moving average of $200.66 and a 200 day moving average of $197.25.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.Danaher's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's payout ratio is currently 27.23%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on DHR shares. Royal Bank Of Canada set a $241.00 price target on Danaher in a research note on Tuesday, September 2nd. Guggenheim restated a "buy" rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Robert W. Baird boosted their price target on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Finally, Evercore ISI boosted their price target on Danaher from $226.00 to $245.00 and gave the stock an "outperform" rating in a research note on Tuesday. Seventeen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $244.60.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.